DekaBank Deutsche Girozentrale’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-402,100
Closed -$607K 1400
2022
Q1
$607K Buy
402,100
+36,600
+10% +$55.3K ﹤0.01% 1025
2021
Q4
$887K Sell
365,500
-184,500
-34% -$448K ﹤0.01% 961
2021
Q3
$1.39M Hold
550,000
﹤0.01% 821
2021
Q2
$1.59M Buy
+550,000
New +$1.59M ﹤0.01% 782